Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00183170 · ClinicalTrials.gov registry record · Phase 2

Residual Effects of Intoxication on Student Performance

A Phase 2 study of Neurobehavioral Manifestations and Alcoholic Intoxication, sponsored by Boston University.

Completed
Registry status
Phase 2
Development phase
239
Enrollment target
1
Study location

NCT00183170 is a Phase 2 study of Neurobehavioral Manifestations and Alcoholic Intoxication that has completed, run by Boston University. The registered enrollment target is 239 participants, below the 687-participant average among 5 other Neurobehavioral Manifestations trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00183170, a Phase 2 study of Neurobehavioral Manifestations and Alcoholic Intoxication, has completed, sponsored by Boston University.

COMPLETED
Registry status
Phase 2
Development phase
239 participants
Enrollment target
1
Study location

Study Summary

The primary goal of the study is to assess the residual effects of heavy drinking on academic performance. The investigators will also explore whether these effects differ by family history of alcohol abuse and hangover symptoms, as well as compare males and females with respect to these effects. The primary hypothesis is that intoxication (0.10 g% blood alcohol concentration \[BAC\]) with an alcoholic beverage impairs next-day academic performance, as measured by scores on quizzes, standardized academic achievement tests, and standardized neurobehavioral assessments. The secondary hypothesis is that family-history-positive individuals will show a greater performance decrement the day after heavy drinking than family-history-negative individuals.

Interventions

  • OTHER Placebo
  • DRUG Alcohol

Study Locations (1)

Massachusetts

  • General Clinical Research Center/Boston University School of Public Health - Boston

Trial Details

FieldValue
Enrollment Target 239 participants
Start Date 2004-02
Est. Completion 2009-01
Phase Phase 2

Sponsor

Boston University

185 total trials

What the Registry Record Tells You About NCT00183170

The ClinicalTrials.gov registry entry for NCT00183170 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 239 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 687-participant average among 5 other Neurobehavioral Manifestations trials with a reported enrollment target (65% lower). The listed sponsor is Boston University, which has 185 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Neurobehavioral Manifestations appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT00183170 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00183170 about?

NCT00183170 is a clinical study titled "Residual Effects of Intoxication on Student Performance". The primary goal of the study is to assess the residual effects of heavy drinking on academic performance. The investigators will also explore whether these effects differ by family history of alcohol abuse and hangover symptoms, as well as compare males and females with respect to these effects. Th...

What is the current status of trial NCT00183170?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 239 participants. The study started on 2004-02. Estimated completion is 2009-01.

What conditions does trial NCT00183170 study?

This clinical trial studies the following conditions: Neurobehavioral Manifestations, Alcoholic Intoxication.

What interventions are being tested in trial NCT00183170?

The interventions under investigation include: Placebo (OTHER), Alcohol (DRUG).

Who is sponsoring clinical trial NCT00183170?

This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00183170 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Neurobehavioral Manifestations

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.